Muley Prasad, Shah Monali, Muley Arti
Department of Paediatrics, S.B.K.S MIRC, Sumandeep Vidyapeeth, Vadodara, Gujarat 391760, India.
Department of Periodontics, K.M.S DCH, Sumandeep Vidyapeeth, Vadodara, Gujarat 391760, India.
J Allergy (Cairo). 2015;2015:312052. doi: 10.1155/2015/312052. Epub 2015 Aug 19.
Asthma is one of the most common respiratory diseases affecting all age groups. The world is now trying to identify some dietary factors which can play a preventive role. We performed this systematic review and meta-analysis of RCTs to assess the effect of intake of polyunsaturated fatty acid (PUFA) in infancy and/or childhood on incidence of asthma or wheezing episodes. We searched MEDLINE, EBSCO, Trip, and Google Scholar up to January 31, 2015. All RCTs where infants or children who were given omega-3 fatty acid supplementation and which reported incidence of asthma and/or wheezing episodes as dichotomous outcomes were included in this review. Random effects model was used for pooling the risk estimates. Total five articles were included. Most of them were from Australia. On meta-analysis, the pooled estimate of odds ratios by random effects model showed no significant change in incidence of asthma after supplementation of omega-3 FA in infancy or childhood (OR 0.974; CI 0.646, 1.469; p = 0.900). We concluded that a multicentric RCT is required to assess the effect of omega-3 FA supplementation exclusively to infants or children to predict the best time of omega-3 FA supplementation to prevent asthmatic or wheezing episodes later in life.
哮喘是影响所有年龄组的最常见呼吸道疾病之一。目前全世界都在努力确定一些能起到预防作用的饮食因素。我们进行了这项随机对照试验(RCT)的系统评价和荟萃分析,以评估婴儿期和/或儿童期摄入多不饱和脂肪酸(PUFA)对哮喘或喘息发作发病率的影响。我们检索了截至2015年1月31日的MEDLINE、EBSCO、Trip和谷歌学术。本评价纳入了所有给予ω-3脂肪酸补充剂的婴儿或儿童的随机对照试验,这些试验将哮喘和/或喘息发作的发病率报告为二分结局。采用随机效应模型汇总风险估计值。共纳入五篇文章。其中大多数来自澳大利亚。荟萃分析显示,随机效应模型得出的优势比汇总估计值表明,婴儿期或儿童期补充ω-3脂肪酸后哮喘发病率无显著变化(优势比0.974;可信区间0.646,1.469;p = 0.900)。我们得出结论,需要进行一项多中心随机对照试验,专门评估向婴儿或儿童补充ω-3脂肪酸的效果,以预测补充ω-3脂肪酸预防日后生活中哮喘或喘息发作的最佳时间。